Skip to main content
. 2018 Apr 19;13(4):e0196081. doi: 10.1371/journal.pone.0196081

Fig 4. Diagnostics performance of triplex miRNA panel in patients with normal AFP level.

Fig 4

Diagnostic performance of the panel Mir@AFP based on the miRNAs miR-21, miR-122, miR-192 and AFP in differentiating hepatocellular carcinoma with normal AFP levels from other conditions (<20 ng/l). (A): HCC vs. CHB; (B): HCC vs. LC; (C): HCC vs. LC+CHB and (D): HCC vs. (LC+CHB+HC).